FTRE
Price
$6.25
Change
+$0.17 (+2.80%)
Updated
May 2, 04:59 PM (EDT)
Capitalization
550.49M
10 days until earnings call
MORN
Price
$293.15
Change
+$9.99 (+3.53%)
Updated
May 2, 04:59 PM (EDT)
Capitalization
13.18B
82 days until earnings call
Ad is loading...

FTRE vs MORN

Header iconFTRE vs MORN Comparison
Open Charts FTRE vs MORNBanner chart's image
Fortrea Holdings
Price$6.25
Change+$0.17 (+2.80%)
Volume$40.52K
Capitalization550.49M
Morningstar
Price$293.15
Change+$9.99 (+3.53%)
Volume$2.3K
Capitalization13.18B
FTRE vs MORN Comparison Chart
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MORN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. MORN commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a StrongBuy and MORN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (FTRE: $6.08 vs. MORN: $283.16)
Brand notoriety: FTRE and MORN are both not notable
FTRE represents the Biotechnology, while MORN is part of the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: FTRE: 75% vs. MORN: 188%
Market capitalization -- FTRE: $550.49M vs. MORN: $13.18B
FTRE [@Biotechnology] is valued at $550.49M. MORN’s [@Investment Banks/Brokers] market capitalization is $13.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $928.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B. The average market capitalization across the [@Investment Banks/Brokers] industry is $12.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileMORN’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • MORN’s FA Score: 0 green, 5 red.
According to our system of comparison, MORN is a better buy in the long-term than FTRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 5 TA indicator(s) are bullish while MORN’s TA Score has 5 bullish TA indicator(s).

  • FTRE’s TA Score: 5 bullish, 3 bearish.
  • MORN’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, MORN is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а +3.75% price change this week, while MORN (@Investment Banks/Brokers) price change was +1.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.36%. For the same industry, the average monthly price growth was +8.08%, and the average quarterly price growth was -5.89%.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was +1.49%. For the same industry, the average monthly price growth was +2.24%, and the average quarterly price growth was +109.84%.

Reported Earning Dates

FTRE is expected to report earnings on May 12, 2025.

MORN is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+4.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Investment Banks/Brokers (+1.49% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MORN($13.2B) has a higher market cap than FTRE($550M). MORN YTD gains are higher at: -15.669 vs. FTRE (-67.399). MORN has higher annual earnings (EBITDA): 427M vs. FTRE (-64.3M). MORN has more cash in the bank: 389M vs. FTRE (118M). MORN (1.16B) and FTRE (1.2B) have identical debt. FTRE has higher revenues than MORN: FTRE (2.7B) vs MORN (2.04B).
FTREMORNFTRE / MORN
Capitalization550M13.2B4%
EBITDA-64.3M427M-15%
Gain YTD-67.399-15.669430%
P/E RatioN/A93.13-
Revenue2.7B2.04B132%
Total Cash118M389M30%
Total Debt1.2B1.16B103%
FUNDAMENTALS RATINGS
MORN: Fundamental Ratings
MORN
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
38
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREMORN
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
48%
Advances
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 3 days ago
65%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 25 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Ad is loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MORN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARSYX14.48N/A
N/A
AB Global Real Estate Investment Advisor
THCGX26.36N/A
N/A
Thornburg Small/Mid Cap Growth A
SCSDX16.55N/A
N/A
Allspring Common Stock Admin
MXYKX4.89N/A
N/A
Empower T. Rowe Price Mid Cp Gr Instl
FTGQX25.65N/A
N/A
Templeton Growth C

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BHVN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BHVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-2.41%
BHVN - FTRE
44%
Loosely correlated
+1.49%
TECH - FTRE
41%
Loosely correlated
-1.43%
JAZZ - FTRE
41%
Loosely correlated
+0.19%
DNLI - FTRE
40%
Loosely correlated
-3.54%
OCUL - FTRE
38%
Loosely correlated
+2.77%
More

MORN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MORN has been closely correlated with MCO. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if MORN jumps, then MCO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MORN
1D Price
Change %
MORN100%
-0.55%
MCO - MORN
75%
Closely correlated
-0.28%
NDAQ - MORN
73%
Closely correlated
-0.09%
SPGI - MORN
71%
Closely correlated
-0.22%
MC - MORN
63%
Loosely correlated
-0.32%
GS - MORN
62%
Loosely correlated
+1.15%
More